No Data
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
10-K: FY2024 Annual Report
Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., Has Completed Its First Good Manufacturing Practice ("GMP") Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin
Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
